Alexander SchwengerHead of LNP Process Development at Lonza
Alexander has more than 10 years of experience in the field of mRNA/LNP gained in academia and the pharmaceutical industry. After completing his Diploma degree, he specialized in nucleic acid chemistry and nano structuring and received his PhD from the University of Stuttgart. He has a long list of publications and has worked in various roles of increasing responsibility at Curevac SE Germany. Since June 2023, Alex is leading the process development for nucleic acid delivery systems at Lonza (Netherlands) and strives to bring this modality to a new level.
All Sessions by Dr. Alexander Schwenger
Title: Next generation of Encapsulation - Optimizing GMP manufacturing of Lipid Nanoparticles
- Current delivery systems for the encapsulation of Nucleic Acids have strengths and weaknesses
- New technologies (next generation) for the encapsulation in development can potentially overcome
limitations of currently available standard mixing technologies
- Results of comparative studies will be presented at the conference